secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2026-06-26T20:07:23+00:00
Accession:  0001437749-26-021833
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart: BARDA modifies COVID-19 trial award to ~$345M; releases $29M for data analysis
--------------------------------------------------------------------------------

- Total BARDA funding reduced ~$116M to ~$345M after 50% participant reduction due to partial termination in Aug 2025.
- Modification releases ~$29M for trial completion and exploratory safety/efficacy analyses.
- Vaxart plans to report 12-month data from 400-participant sentinel cohort in coming weeks; main cohort (5,085) data in H1 2027.
- CEO states modification is necessary step to unblinding and reporting first data set.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774926021833/0001437749-26-021833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774926021833/vxrt20260626_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-021833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer